Immunic Inc (NASDAQ: IMUX) open the trading on Wednesday, with great promise as it jumped 3.27% to $0.71, before settling in for the price of $0.69 at the close. Taking a more long-term approach, IMUX posted a 52-week range of $0.56-$2.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 26.01%. Meanwhile, its Annual Earning per share during the time was 26.01%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 28.99%. This publicly-traded company’s shares outstanding now amounts to $95.82 million, simultaneously with a float of $92.55 million. The organization now has a market capitalization sitting at $68.32 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8946, while the 200-day Moving Average is $1.1168.
Immunic Inc (IMUX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Immunic Inc’s current insider ownership accounts for 3.42%, in contrast to 40.58% institutional ownership. According to the most recent insider trade that took place on Jun 13 ’25, this organization’s Executive Chairman bought 20,000 shares at the rate of 0.83, making the entire transaction reach 16,694 in total value, affecting insider ownership by 36,032. Preceding that transaction, on Jun 05 ’25, Company’s President and COO bought 12,512 for 0.79, making the whole transaction’s value amount to 9,884. This particular insider is now the holder of 12,512 in total.
Immunic Inc (IMUX) Earnings and Revenue Records
Immunic Inc’s EPS increase for this current 12-month fiscal period is 28.99% and is forecasted to reach -0.57 in the upcoming year.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Let’s observe the current performance indicators for Immunic Inc (IMUX). It’s Quick Ratio in the last reported quarter now stands at 0.74.
In the same vein, IMUX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.98, a figure that is expected to reach -0.17 in the next quarter, and analysts are predicting that it will be -0.57 at the market close of one year from today.
Technical Analysis of Immunic Inc (IMUX)
[Immunic Inc, IMUX] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 19.11% While, its Average True Range was 0.0583.
Raw Stochastic average of Immunic Inc (IMUX) in the period of the previous 100 days is set at 18.43%, which indicates a major rise in contrast to 17.69% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 39.33% that was lower than 94.50% volatility it exhibited in the past 100-days period.
